| |
| |
|
| Insider
Information: |
Berger Harvey J MD |
| Relationship: |
Chairman & CEO, Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,732,111 |
|
|
Indirect Shares
|
2,604,336 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
4,336,447 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ariad Pharmaceuticals Inc |
ARIA |
Chairman & CEO, Director |
2015-12-31 |
1,732,111 |
2015-12-31 |
2,604,336 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2009-08-04 |
4 |
B |
$1.75 |
$3,000,001 |
I/I |
1,714,286 |
1,714,286 |
2.66 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-07-16 |
4 |
AS |
$19.91 |
$2,866,478 |
D/D |
(144,000) |
1,405,861 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-04-17 |
4 |
AS |
$18.01 |
$1,800,590 |
D/D |
(100,000) |
1,667,521 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2015-12-31 |
4 |
D |
$6.25 |
$1,777,381 |
D/D |
(284,381) |
1,732,111 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-08-14 |
4 |
AS |
$18.51 |
$1,164,335 |
D/D |
(62,902) |
1,242,759 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2015-03-26 |
4 |
OE |
$7.56 |
$1,134,000 |
D/D |
150,000 |
1,446,175 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-03-13 |
4 |
AS |
$22.06 |
$1,102,990 |
D/D |
(50,000) |
1,676,089 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-03-12 |
4 |
AS |
$22.04 |
$1,101,755 |
D/D |
(50,000) |
1,726,089 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2015-03-26 |
4 |
D |
$8.17 |
$1,039,175 |
D/D |
(127,194) |
1,343,460 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-07-17 |
4 |
AS |
$19.61 |
$980,705 |
D/D |
(50,000) |
1,355,861 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-08-13 |
4 |
AS |
$18.11 |
$905,555 |
D/D |
(50,000) |
1,305,661 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-05-14 |
4 |
AS |
$18.01 |
$900,295 |
D/D |
(50,000) |
1,553,935 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-03-22 |
4 |
D |
$19.38 |
$894,348 |
D/D |
(46,148) |
1,745,543 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2014-09-09 |
4 |
OE |
$5.23 |
$784,500 |
D/D |
150,000 |
1,294,277 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-07-15 |
4 |
D |
$20.98 |
$729,600 |
D/D |
(34,776) |
1,549,861 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2014-09-09 |
4 |
D |
$5.75 |
$716,525 |
D/D |
(124,613) |
1,163,564 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-05-15 |
4 |
AS |
$18.22 |
$675,970 |
D/D |
(37,098) |
1,516,837 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2012-03-22 |
4 |
D |
$15.68 |
$639,368 |
D/D |
(40,776) |
2,146,676 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2012-12-18 |
4 |
D |
$20.18 |
$526,577 |
D/D |
(26,094) |
2,226,089 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2007-07-09 |
4 |
OE |
$4.05 |
$466,254 |
D/D |
107,372 |
748,790 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-04-01 |
4 |
D |
$18.30 |
$360,290 |
D/D |
(19,688) |
1,767,521 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & Chief Exec Officer |
• • – |
2007-05-17 |
4 |
OE |
$0.75 |
$346,466 |
D/D |
224,455 |
641,418 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-03-20 |
4 |
D |
$20.45 |
$328,529 |
D/D |
(16,065) |
1,694,024 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-12-18 |
4 |
D |
$4.98 |
$146,910 |
D/D |
(29,500) |
1,050,759 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2015-07-15 |
4 |
D |
$8.35 |
$145,040 |
D/D |
(17,370) |
1,366,492 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
